Catalyst Wire Dossier Catalyst Wire Dossier

H7N1 influenza vaccine (GSK)

influenza vaccine H7N1 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H7N1 influenza vaccine (GSK), covering 2017-11-17 to 2017-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older [Phase 2]

See pricing